Dystonia
is
the
third
most
common
movement
disorder.
It
causes
debilitating
twisting
postures
that
are
accompanied
by
repetitive
and
sometimes
intermittent
co-
or
over-contractions
of
agonist
antagonist
muscles.
Historically
diagnosed
as
a
basal
ganglia
disorder,
dystonia
increasingly
considered
network
disorder
involving
various
brain
regions
including
cerebellum.
In
certain
etiologies
dystonia,
aberrant
motor
activity
generated
in
cerebellum
abnormal
signals
then
propagate
through
“dystonia
circuit”
includes
thalamus,
ganglia,
cerebral
cortex.
Importantly,
it
has
been
reported
non-motor
defects
can
accompany
symptoms;
while
their
severity
not
always
correlated,
hypothesized
pathways
may
nevertheless
be
disrupted.
particular,
circadian
dysfunction
disordered
sleep
patient
complaints
dystonia.
Given
recent
evidence
suggesting
contains
oscillator,
displays
sleep-stage-specific
neuronal
activity,
sends
robust
long-range
projections
to
several
subcortical
involved
rhythm
regulation,
result
from
cerebellum-mediated
circuit.
Here,
we
review
linking
cerebellar
dysfunction,
involvement
sleep.
Together,
these
ideas
form
basis
for
development
improved
pharmacological
surgical
interventions
could
take
advantage
circuitry
restore
normal
function
well
(sleep)
behaviors
Frontiers in Neurology,
Год журнала:
2022,
Номер
13
Опубликована: Март 9, 2022
Deep
brain
stimulation
(DBS)
has
advanced
treatment
options
for
a
variety
of
neurologic
and
neuropsychiatric
conditions.
As
the
technology
DBS
continues
to
progress,
efficacy
will
continue
improve
disease
indications
expand.
Hardware
advances
such
as
longer-lasting
batteries
reduce
frequency
battery
replacement
segmented
leads
facilitate
improvements
in
effectiveness
have
potential
minimize
side
effects.
Targeting
specialized
imaging
sequences
“connectomics”
improved
accuracy
lead
positioning
trajectory
planning.
Software
closed-loop
remote
programming
enable
be
more
personalized
accessible
technology.
The
future
promising
holds
further
quality
life.
In
this
review
we
address
past,
present
DBS.
Trends in Neurosciences,
Год журнала:
2023,
Номер
46(6), С. 472 - 487
Опубликована: Апрель 25, 2023
Deep
brain
stimulation
(DBS)
is
an
effective
treatment
and
has
provided
unique
insights
into
the
dynamic
circuit
architecture
of
disorders.
This
Review
illustrates
our
current
understanding
pathophysiology
movement
disorders
their
underlying
circuits
that
are
modulated
with
DBS.
It
proposes
principles
pathological
network
synchronization
patterns
like
beta
activity
(13–35
Hz)
in
Parkinson's
disease.
We
describe
alterations
from
microscale
including
local
synaptic
via
modulation
mesoscale
hypersynchronization
to
changes
whole-brain
macroscale
connectivity.
Finally,
outlook
on
advances
for
clinical
innovations
next-generation
neurotechnology
provided:
preoperative
connectomic
targeting
feedback
controlled
closed-loop
adaptive
DBS
as
individualized
network-specific
interventions.
npj Parkinson s Disease,
Год журнала:
2022,
Номер
8(1)
Опубликована: Июль 8, 2022
Beta-band
activity
in
the
subthalamic
local
field
potential
(LFP)
is
correlated
with
Parkinson's
disease
(PD)
symptom
severity
and
therapeutic
target
of
deep
brain
stimulation
(DBS).
While
beta
fluctuations
PD
patients
are
well
characterized
on
shorter
timescales,
it
not
known
how
evolves
around
diurnal
cycle,
outside
a
clinical
setting.
Here,
we
obtained
chronic
recordings
(34
±
13
days)
power
implanted
Percept
DBS
device
during
high-frequency
analysed
their
properties
as
sensitivity
to
artifacts.
Time
day
explained
41
9%
variance
(p
<
0.001
all
patients),
increased
reduced
at
night.
Certain
movements
affected
LFP
quality,
which
may
have
contributed
patterns
some
patients.
Future
algorithms
benefit
from
taking
such
artifactual
into
account.
medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2023,
Номер
unknown
Опубликована: Авг. 8, 2023
Deep
brain
stimulation
is
a
widely
used
therapy
for
Parkinson's
disease
(PD)
but
currently
lacks
dynamic
responsiveness
to
changing
clinical
and
neural
states.
Feedback
control
has
the
potential
improve
therapeutic
effectiveness,
optimal
strategy
additional
benefits
of
"adaptive"
neurostimulation
are
unclear.
We
implemented
adaptive
subthalamic
nucleus
stimulation,
controlled
by
or
cortical
signals,
in
three
PD
patients
(five
hemispheres)
during
normal
daily
life.
identified
neurophysiological
biomarkers
residual
motor
fluctuations
using
data-driven
analyses
field
potentials
over
wide
frequency
range
varying
amplitudes.
Narrowband
gamma
oscillations
(65-70
Hz)
at
either
site
emerged
as
best
signal
sensing
stimulation.
A
blinded,
randomized
trial
demonstrated
improved
symptoms
quality
life
compared
clinically
optimized
standard
Our
approach
highlights
promise
personalized
based
on
selection
signals
may
be
applied
other
neurological
disorders.
Brain stimulation,
Год журнала:
2024,
Номер
17(1), С. 125 - 133
Опубликована: Янв. 1, 2024
BackgroundDeep
brain
stimulation
(DBS)
is
an
invasive
treatment
option
for
patients
with
Parkinson's
disease.
Recently,
adaptive
DBS
(aDBS)
systems
have
been
developed,
which
adjust
timing
and
amplitude
in
real-time.
However,
it
unknown
how
changes
parameters,
movement
states
the
controllability
of
subthalamic
beta
activity
affect
aDBS
performance.ObjectiveTo
characterize
parameter
choice,
state
interactively
electrophysiological
behavioral
response
to
single
threshold
aDBS.MethodsWe
recorded
local
field
potentials
12
disease
receiving
acute
post-operative
state.
We
investigated
two
parameters:
onset
time
smoothing
real-time
power.
Electrophysiological
patterns
motor
performance
were
assessed
while
at
rest
during
a
simple
task.
further
studied
impact
on
by
comparing
without
power
modulation
continuous
stimulation.ResultsOur
findings
reveal
that
control
extent
suppression
achievable
rest.
Behavioral
data
indicate
only
specific
combinations
yield
beneficial
effect
aDBS.
During
movement,
action
induced
reduces
responsivity
closed
loop
algorithm.
demonstrate
prerequisite
effective
dependent
activity.ConclusionOur
results
highlight
interaction
between
selection,
driving
performance.
By
this
means,
we
identify
directions
development
closed-loop
algorithms.
Nature Communications,
Год журнала:
2024,
Номер
15(1)
Опубликована: Фев. 27, 2024
Abstract
Sleep
disturbance
is
a
prevalent
and
disabling
comorbidity
in
Parkinson’s
disease
(PD).
We
performed
multi-night
(n
=
57)
at-home
intracranial
recordings
from
electrocorticography
subcortical
electrodes
using
sensing-enabled
Deep
Brain
Stimulation
(DBS),
paired
with
portable
polysomnography
four
PD
participants
one
cervical
dystonia
(clinical
trial:
NCT03582891).
Cortico-basal
activity
delta
increased
beta
decreased
during
NREM
(N2
+
N3)
versus
wakefulness
PD.
DBS
caused
further
elevation
cortical
decrease
alpha
low-beta
compared
to
OFF
state.
Our
primary
outcome
demonstrated
an
inverse
interaction
between
slow-wave
NREM.
secondary
revealed
increases
prior
spontaneous
awakenings
classified
vs.
high
accuracy
both
traditional
(30
s:
92.6
±
1.7%)
rapid
(5
88.3
2.1%)
data
epochs
of
signals.
findings
elucidate
sleep
neurophysiology
impacts
on
informing
adaptive
for
dysfunction.
Nature Communications,
Год журнала:
2023,
Номер
14(1)
Опубликована: Сен. 5, 2023
Parkinson's
disease
(PD)
is
associated
with
excessive
beta
activity
in
the
basal
ganglia.
Brain
sensing
implants
aim
to
leverage
this
biomarker
for
demand-dependent
adaptive
stimulation.
Sleep
disturbance
among
most
common
non-motor
symptoms
PD,
but
its
relationship
unknown.
To
investigate
clinical
potential
of
as
a
sleep
quality
we
recorded
pallidal
local
field
potentials
during
polysomnography
PD
patients
off
dopaminergic
medication
and
compared
results
dystonia
patients.
exhibited
sustained
elevated
across
wakefulness,
rapid
eye
movement
(REM),
non-REM
sleep,
which
was
correlated
disturbance.
Simulation
stimulation
revealed
that
sleep-related
changes
remain
unaccounted
by
current
algorithms,
negative
outcomes
overall
life
Brain,
Год журнала:
2023,
Номер
146(12), С. 5015 - 5030
Опубликована: Июль 11, 2023
Abstract
Subthalamic
nucleus
(STN)
beta-triggered
adaptive
deep
brain
stimulation
(ADBS)
has
been
shown
to
provide
clinical
improvement
comparable
conventional
continuous
DBS
(CDBS)
with
less
energy
delivered
the
and
induced
side
effects.
However,
several
questions
remain
unanswered.
First,
there
is
a
normal
physiological
reduction
of
STN
beta
band
power
just
prior
during
voluntary
movement.
ADBS
systems
will
therefore
reduce
or
cease
movement
in
people
Parkinson’s
disease
could
compromise
motor
performance
compared
CDBS.
Second,
was
smoothed
estimated
over
time
period
400
ms
most
previous
studies,
but
shorter
smoothing
have
advantage
being
more
sensitive
changes
power,
which
enhance
performance.
In
this
study,
we
addressed
these
two
by
evaluating
effectiveness
using
standard
200
window
reaching
movements.
Results
from
13
showed
that
reducing
for
quantifying
did
lead
shortened
burst
durations
increasing
number
bursts
than
frequent
switching
on/off
stimulator
had
no
behavioural
Both
CDBS
improved
an
equivalent
extent
DBS.
Secondary
analysis
revealed
were
independent
effects
decrease
increase
gamma
predicting
faster
speed,
while
event
related
desynchronization
(ERD)
predicted
quicker
initiation.
suppressed
both
ADBS,
whereas
ERD
reduced
similar
level
DBS,
together
explained
achieved
movements
ADBS.
addition,
significantly
tremor
not
as
effective
These
results
suggest
improving
disease,
shortening
does
result
any
additional
benefit.
When
developing
it
might
be
necessary
track
very
fast
dynamics;
combining
beta,
gamma,
information
decoding
beneficial
biomarkers
needed
optimal
treatment
tremor.